Skip to main content
PLOS One logoLink to PLOS One
. 2021 Jun 4;16(6):e0252538. doi: 10.1371/journal.pone.0252538

Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards nutraceuticals: A hospital based cross-sectional study in Kavrepalanchok, Nepal

Rabi Shrestha 1,#, Sweta Shrestha 2,*,#, Badri K C 2,, Sunil Shrestha 3,
Editor: Jenny Wilkinson4
PMCID: PMC8177421  PMID: 34086755

Abstract

Background

There is substantial increment in nutraceutical consumption in Nepal, although the data on its efficacy and safety is scarce. The practices of nutraceutical supplements users in Nepal remain undocumented. Therefore, this study was conducted to study the prescription pattern, cost, knowledge, attitude and practice (KAP) of the patient towards nutraceutical.

Methods

Descriptive cross-sectional study with stratified purposive sampling (n = 400) (patients from the out-patient departments of Scheer Memorial Adventist Hospital, Kavre, Nepal) was performed using a validated structured questionnaire assessing the socio-demographic characteristics, knowledge, attitude, practice of nutraceutical and total cost patients spent on nutraceutical alone. Pearson Chi-square test (x2) was used to investigate the association between socio-demographic variables and patients’ KAP (knowledge, attitude and practice) towards nutraceutical. One way ANOVA was performed to compare the cost of nutraceutical among the different outpatient departments.

Results

More than 80% of patients were found to be consuming nutraceutical on their own. The mostly prescribed nutraceutical were vitamins (40.7%), minerals (23.7%), enzymes (21.1%), proteins (8.8%), probiotics (4.2%) and herbals (2.0%). With the most common reasons for consuming nutraceutical were to maintain good health (70.0%) and healthcare professionals (57.85%) were the most approached source of information for nutraceutical. Nearly half of the patients (46.5%) had an inadequate level of knowledge whereas more than two-third (71.5%) showed a moderate positive attitude towards nutraceutical use. The average amount patients spent was NRs.575.78 [equivalent to USD 4.85] per prescription on nutraceutical alone. The maximum cost amounted to NRs 757.18 [equivalent to USD 6.43] in Orthopedics, and the minimum cost was NRs 399.03 [equivalent to USD 3.36] in Obstetrics and gynecology, respectively. There was a significant difference (p <0.001) in cost of nutraceutical prescribed between the OPD clinics.

Conclusion

The higher prevalence of inadequate knowledge despite moderate positive attitude towards nutraceutical among patients regarding some significant issues such as safety and interactions of nutraceutical consumption and its’ substitution for meals reflects the need to develop an educational strategy to increase general public awareness on the rational use of nutraceutical.

Introduction

Nutraceuticals is a term coined from the words “nutrition” and “pharmaceutical” which has been defined as “food or part of a food that provides medical or health benefits including the prevention and/or treatment of a disease" [1, 2]. The global data indicates the growing trend of functional food and nutraceutical market compared to the traditional food market [3]. This could be further supported by the Price waterhouse Coopers (PWC) analysis that has shown sharp growth in sales of vitamins and dietary supplements in global market by 6.3% (compound annual growth rate (CAGR) 2014–2018) and resulting the market size valued at USD 382.51 billion in 2019. It is expected that the market size further expands by 8.3% from 2016–2027 [4]. The global pharmaceutical manufacturing market size was valued at USD 324.42 billion in 2019 and is expected to grow at a CAGR of 13.74% from 2020 to 2027. Despite higher market size of a nutraceutical compared to pharmaceutical, there is lack in strict regulation of nutraceutical products. This could be evidenced by individuals easy access to nutraceuticals through supermarkets, pharmacies and internet [5]. The likelihood of in vivo clinical data to determine and assess nutraceutical safety and efficacy is relatively low and hence it could raise concern over the proven benefit from their usage [6].

The fastest-growing market for nutraceutical is South East Asia, with an estimated CAGR of 12% [7]. The higher use of nutraceutical is reflected by its emerging as a mainstream product and becoming a part of consumers’ daily diet. The primary reasons for this dramatic shift can be attributed to rapid urbanization, increased prevalence of lifestyle diseases and people consciously taking preventive healthcare measures in form of dietary supplements [4]. Although a group of non-governmental organizations are advocating for including dietary supplements and nutraceuticals in the World Health Organization (WHO) model list of essential medicines to increase their access, WHO has not yet declared the inclusion of those products till date, from the ongoing consultation [8].

Meanwhile adverse event (AE) reporting for all the medicines is compulsory, only a very few countries have similar regulation for dietary supplements. In US, Congress passed the Dietary Supplement and Nonprescription Drug Consumer Protection Act in 2006. Between 2008 and 2011, the Food and Drug Administration (FDA) received over 4300 AE reports from the industry, but before enacting it used to be voluntary with many reports from other than the industry [9]. The efficacy of fish oils (e.g., cod liver oil) in the diet has been demonstrated in several clinical trials, animal feeding experiments and in vitro models that mimic cartilage destruction in arthritic disease. Also, there is some evidence for beneficial effects of other nutraceuticals, such as green tea, herbal extracts, chondroitin sulphate and glucosamine [10]. However, many dietary supplements lack scientific evidence for or against the use, and yet they continue to be widely ingested throughout the world [11].

In context to Nepal, Dietary Supplement Guideline has been published by the Ministry of Agriculture and Livestock Development, regulating the nutraceuticals. However, unwarranted prescribing of nutraceuticals by physicians for financial benefits from the manufacturers has been reported continuously. Department of drug administration (DDA) has been attempting to stop such practices, putting the patients at a high economic burden and possible health hazard. Risky behaviors like the purchase of unauthorized herbal formulations and nutraceuticals from street vendors are prevalent in Nepal, which must be brought to a complete halt [12].

There are numerous nutraceutical products that have been claimed to offer a cure for many diseases, thus misleading chronic disease patients to use these products although scientific evidence backing such claims are lacking [13]. The claims of an energy booster, weight loss, enhanced appearance and other miraculous benefits for different illnesses may have prompted many consumers to fall for these unscientific assertions [14]. Lack of stringent regulations to benchmark nutraceutical use reflects the need to explore the current prescription practice and consumption of nutraceuticals among patients. Furthermore, it becomes essential to investigate the patients’ knowledge, attitude and practice of nutraceutical to customize the educational programs to ensure the appropriate use of these supplements. With this background, the current study was conducted considering the paucity of data regarding prescribing of nutraceuticals and the lack of information of patients’ knowledge, attitude, and practice of nutraceuticals in context of Nepal.

Materials and methods

Study design, study site, population characteristics and ethical approval

A descriptive cross-sectional study was conducted at Scheer Memorial Adventist Hospital (SMAH), Kavrepalanchok, Nepal. SMAH has 150-bed facilities and is located near Kathmandu, the capital city of Nepal, and provides a full range of out-patient and in-patient services. Ethical approval was obtained before data collection from the Scheer Memorial Adventist Hospital (SMAH) Ethical Review Committee.

The study population consisted of patients who visited the out-patient department (OPD) of SMAH (medicine, surgery, orthopedic, and obstetrics and gynecology) during the study period of three months from June 2019 to August 2019. Patients prescribed with nutraceuticals visiting the OPD of SMAH (medicine, surgery, orthopedic, and obstetrics and gynecology) and thus agreed to provide written consent to participate in the study were included. The excluded criteria included patients visiting emergency departments and mentally disabled patients.

Privacy and confidentiality were maintained by not disclosing the name of the participants and ensuring them, that collected information was used only for the study purpose. The parents or guardians were interviewed, and they provided informed consent in representation of the minors as a part of the study. The interviewer administered the questionnaire to each participant and any explanation required was provided to the respondents.

Sampling method and technique

The sample size was calculated using the Raosoft online calculator [15]. Raosoft online calculator is designed specifically for population surveys to calculate the sample size and determine how many responses are needed to meet the desired confidence level with the margin of error (usually 5%) [15]. According to the hospital census, the total population of patients visiting OPD is 22500 (with an average 250 per day) in a three-month duration. Therefore, to achieve a confidence level of 95% and a 5% margin of error and 50% response distribution, a minimum sample size of 378 was required. Stratified purposive sampling was performed. The SMAH has mainly 5 outpatient clinics; medicine, orthopedic, gynecology, surgery and pediatrics. Pediatrics were excluded, and data collection was done in remaining four departments. Total of 400 patients and 100 from each department were taken to distribute sample in strata properly.

Estimation of the minimum number of respondents to be included can be obtained by using the formula given below,

n=N.Zα/22.P(1P)/[(N1)e2+Zα/22.P(1P)]

Where,

n = minimum sample size of the study subject

N = total number patient visited in three-month duration as per census

Z = standard normal distribution curve /value at α/2 for the 95% confidence interval (1.96)

P = proportion of the population with KAP of nutraceutical among respondents (50%)

e = the margin of error (0.05).

Data collection tool and technique

An interviewer-administered questionnaire (See S1 File) was designed after reviewing the previous similar studies with some modifications [1618]. The questionnaire was reviewed and subjected to a validation process. The questionnaire was tested for readability and comprehensibility among 38 patients (10% of 378) visiting SMAH. Colleagues from the pharmacy department did face validation of the questionnaire and the content validation of the data collection tool was conducted by discussing the questionnaire with content experts of pharmacy practice, physicians, nutrition expert and statistician. Cronbach’s alpha value was calculated as a measure of the internal consistency of the questionnaire which was found to be 0.783. The outcomes of the pre-testing were not included in the final data analysis.

The final version of the data collection tool comprised of four sections. Section 1 consisted of 7 questions investigating the demographic and related information of patients: age, gender, religion, degree/education, marital status and occupation. Section 2 comprised of 8 items to evaluate the practice of nutraceutical use among patients. Section 3 comprised of 3 items aimed to evaluate patients’ knowledge of nutraceutical and section 4 included 14 items designed to evaluate the attitude of patients towards nutraceutical.

Scoring system

To assess the respondents’ knowledge on nutraceutical, each correct answer was coded as ’yes’ and scored as ’1’, and an incorrect answer was coded as ’no’ and scored as ’0’. Any "I do not know" response was also scored as ’0’. The cumulative and mean scores were calculated. Based on the mean score obtained, participant’s knowledge was categorized as "Adequate" (0.75–1), "moderately adequate" (0.5–0.749) and "inadequate" (<0.5). To assess respondents’ attitude, a five-point Likert scale was used that ranges from; "Strongly agree" i.e., ’1’ to "Strongly disagree" i.e., ’5’. Based on the mean score, the respondents who scored above the mean score were defined as having a "positive attitude" (4–5), "moderate positive attitude" (3–3.99) and those who scored below the mean score were defined as having a "negative attitude"(<3).

Cost calculation

The cost for the individual category of nutraceutical and other medications were noted. The total cost that the patient spent on nutraceutical compared to the total cost of prescribed drugs was calculated using the formula below:

Average nutraceutical cost % on prescription = (Total cost of nutraceutical/Total prescription cost) *100%

Data management and analysis

Data was entered and analyzed using Statistical Package for Social Sciences (SPSS) version 20 (SPSS Inc., Chicago, IL, USA) and p <0.05 was considered as statistically significant in all the analyses. Descriptive analysis was performed using frequencies and percentages. Data was presented in the form of text, figures, and tables. Pearson Chi-square test (x2) for independence was used to determine the association among socio-demographic variables and patients’ knowledge, attitude and practice (KAP) towards nutraceutical. One-way Analysis of variance (ANOVA) test was used to compare the cost of nutraceutical among different departments.

Results

Socio-demographic characteristics

Table 1 shows the socio-demographic characteristics of the patients visiting the out-patient department of SMAH Kavrepalanchok, Nepal. The majority (40%, n = 160) of the participants were of the age group 30–44. Female participants were higher (52.75%, n = 211), and the majority were Newar (33.50%, n = 134) and followed Hindu religion (76.25%, n = 305). Most participants had an education level of higher secondary and above (43.75%, n = 175) and were service holders (28%, n = 112).

Table 1. Socio-demographic characteristics of the respondents (N = 400).

Characteristics Frequency (n) Percentage (%)
Age (in years)
15–29 122 30.50
30–44 160 40
45–59 99 24.75
> 60 19 24.75
Gender
Male 189 47.25
Female 211 52.75
Ethnicity
Brahmin 50 12.50
Chhetri 85 21.25
Newar 134 33.50
Others 131 32.75
Religion
Hindu 305 76.25
Buddhist 67 16.75
Christian 21 5.25
Others 7 1.75
Degree/Education
Illiterate 28 7
Able to read and write 42 10.50
Primary Level 35 8.75
Secondary Level 120 30
Higher secondary and above 175 8.75
Occupation
Housewife 105 26.25
Service 112 28
Business 86 21.50
Others 97 24.25

Prescribing pattern of nutraceuticals

More than three quarters of patients (n = 325, 81.2%) were already using nutraceutical. Frequency of prescribing of different nutraceutical was observed in the following departments: medicine OPD, surgery OPD, orthopedic OPD and Obstetrics and gynecology OPD. Vitamins, Minerals, Enzymes, Proteins, Probiotics and Herbals in decreasing frequency orders were the most frequently prescribed nutraceuticals in the OPD departments (Table 2).

Table 2. Percentage of nutraceuticals prescribed.

S. N. Nutraceuticals Frequency (N = 540) Percentage (%)
1 Vitamins 220 40.7
2 Minerals 128 23.7
3 Enzymes 114 21.1
4 Proteins 48 8.8
5 Probiotics 23 4.2
6 Herbal 11 2

An average number of drugs and nutraceuticals prescribed per prescription were 3.42 and 1.52, respectively.

Gender wise distribution of knowledge and practice on nutraceutical use

Majority of the participants (46.5%, n = 186) had inadequate knowledge followed by moderate adequate knowledge (36.30%, n = 145) whereas only few (17.3%, n = 69) had adequate knowledge on nutraceutical. Most of the participants (90.2%, n = 361), especially the females (90.5%, n = 191) claimed to know about nutraceutical with no significant difference between the male and female (p = 0.847). More than one-third of participants (38%, n = 152) believed that nutraceutical is safe to consume and majority 36.2% (n = 145) opined that nutraceutical interacts with drug, food or drinks with no significant difference between male and female participants (p = 0.812) and (p = 0.293) respectively.

There was no significant difference in the consumption rate of nutraceutical between male and female (p = 0.37). Majority of both male and female respondents (87.5%, n = 350) believed that counselling is essential before consuming nutraceuticals (p = 0.664), but a significantly higher proportion of female (90%, n = 190) consulted for professional medical help when taking nutraceuticals (p = 0.004). Health professionals were the most approached source of information for nutraceuticals by majority of the participants, (57.85%, n = 231) followed by multimedia (17.5%), books (12%), friends (8.2%) and others (4.5%). However, no significant difference between male and female partakers (p = 0.173) was observed in this regard. About half of the respondents (49.2%, n = 197) believed that the information available on nutraceuticals was adequate, with a significantly higher proportion of female undertaking this belief (p = 0.005).

More than two-third (72.5%, n = 290) of the respondents bought nutraceuticals with the prescription, and there was no significant difference in the self-medication practice between male and female (p = 0.26). Majority of them (58%, n = 232) bought nutraceuticals from the hospital pharmacy, followed by community pharmacy (34.8%), others (4.8%) and department store (2.5%) with no significant difference in place of buying between male and female participants (p = 0.502) (Table 3).

Table 3. Gender wise distribution of knowledge and practice question (Chi-square test).

Question (Knowledge) Options Total participants (%) Male (%) Female (%) p-Value
Do you know what nutraceutical are? Yes 361 (90.2%) 170(89.9%) 191(90.5%) 0.847
No 39 (9.8%) 19 (10.1%) 20 (9.5%)
Are uses of nutraceuticals always safe? Yes 152 (38%) 70 (37.0%) 82 (38.9%) 0.812
No 127 (31.8%) 63 (33.3%) 64 (30.3%)
Don’t Know 121 (30.2%) 56 (29.6%) 65 (30.8%)
Can drug/food/drinks interact with nutraceutical? Yes 145 (36.2%) 63 (33.3%) 82 (38.9%) 0.293
No 85 (21.2%) 38 (20.1%) 47 (22.3%)
Don’t Know 170 (42.5%) 88 (46.6%) 82 (38.9%)
Question (Practice)
Do you use any nutraceutical? Yes 325 (81.2%) 147 (77.8%) 178 (84.4%) 0.092
No 75 (18.8%) 42 (22.2%) 33 (15.6%)
How often do you consume nutraceutical? Occasionally 222 (55.5%) 111 (58.7%) 111 (52.6%) 0.37
3 to 5 times a week 58 (14.5%) 23 (12.2%) 35 (16.6%)
Daily 82 (20.5%) 35 (18.5%) 47 (22.3%)
Not sure 38 (9.5%) 20 (10.6%) 18 (8.5%)
Is counseling on nutraceutical important? Yes 350 (87.5%) 168 (88.9%) 182 (86.3%) 0.664
No 22 (5.5%) 10 (5.3%) 12 (5.7%)
Don’t Know 28 (7.0%) 11 (5.8%) 17 (8.1%)
Do you consult medical personnel for nutraceutical? Yes 341 (85.2%) 151 (79.9%) 190 (90.0%) 0.004
No 59 (14.8%) 38 (20.1%) 21 (10.0%)
What is the source of information? Health professionals 231 (57.8%) 100 (52.9%) 131 (62.1%) 0.173
Friends 33 (8.2%) 15 (7.9%) 18 (8.5%)
Multimedia 70 (17.5%) 39 (20.6%) 31 (14.7%)
Books 48 (12.0%) 28 (14.8%) 20 (9.5%)
Others 18 (4.5%) 11 (5.2%) 7 (3.7%)
Is information available are adequate? Yes 197 (49.2%) 77 (40.7%) 120 (56.9%) 0.005
No 115 (28.7%) 62 (32.8%) 53 (25.1%)
Don’t Know 88 (22.0%) 50 (26.5%) 38 (18.0%)
How do you buy nutraceutical? With prescription 290 (72.5%) 132 (69.8%) 158 (74.9%) 0.26
Without prescription 110 (27.5%) 57 (30.2%) 53 (25.1%)
From where did you buy nutraceutical? Hospital pharmacy 232 (58.0%) 106 (56.1%) 126 (59.7%) 0.502
Community Pharmacy 139 (34.8%) 67 (35.4%) 72 (34.1%)
Department store 10 (2.5%) 7 (3.7%) 3 (1.4%)
Others 19 (4.8%) 9 (4.8%) 10 (4.7%)
Summary of Knowledge Level F (n = 400) Percentage (%)
Level of Knowledge (mean score)
Inadequate Knowledge (<0.5) 186 46.5
Moderate Adequate Knowledge (0.5–0.749) 145 36.3
Adequate Knowledge (0.75–1) 69 17.3

Patients’ attitude on nutraceutical use

Table 4 presents the patients attitude on nutraceutical use. Majority of the participants (69%, n = 276), believed that nutraceutical serve as energy booster, enhance physical appearance (74.3%, n = 297), is necessary for all ages (77.3%, n = 309), is harmless (65.5%, n = 262) and can prevent chronic diseases (60.5%, n = 242) or even cancers (35.3%, n = 141). Most of them believed that healthcare professionals should promote the use of nutraceutical (67.3%, n = 269) which should as well be looked upon by some regulatory body (82.3%, n = 329) and it should be categorized as a prescription-only medicine (71%, n = 284). Nutraceuticals use accounts for unnecessary expenditure was disagreed by a maximal number of participants (88.3%, n = 353). The statement that nutrition received from food is inadequate and requires supplementation from nutraceutical was accorded by 69.3% (n = 277), and it aids in losing body fat was consented by 39% (n = 156). Some also believed that nutraceutical could be a substitute for meals (9.8%, n = 39). Majority (21.3%, n = 85) had a negative attitude, 71.5% (n = 286) had a moderately positive attitude, whereas only 7.2% (n = 29) of participants possessed positive attitude regarding the use of nutraceutical.

Table 4. Percentage distribution of respondents’ attitude towards nutraceutical.

S.NO. Attitude variables Percentage distribution of respondents’ attitude towards nutraceutical
Strongly Agree n (%) Agree n (%) Neutral n (%) Disagree n (%) Strongly Disagree n (%)
1 Nutraceuticals are needed if a person feels tired and rundown. 90 (22.5) 186 (46.5) 47 (11.8) 52 (13.0) 25 (6.3)
2 Nutraceutical make one feel better physically. 77 (19.3) 228 (57.0) 50 (12.5) 28 (7.0) 17 (4.3)
3 Nutraceuticals usually improve a person’s appearance. 75 (18.8) 222 (55.5) 44 (11.0) 34 (8.5) 25 (6.3)
4 Body fat can be lost by taking certain type of nutraceuticals. 24 (6.0) 132 (33.0) 125 (31.3) 88 (22.0) 31 (7.8)
5 One can skip meals and just take nutraceuticals. 7 (1.8) 32 (8.0) 45 (11.3) 210 (52.5) 106 (26.5)
6 The nutrients supplied by food need to be supplemented. 45 (11.3) 232 (58.0) 56 (14.0) 46 (11.5) 21 (5.3)
7 Nutraceuticals is necessary for all ages. 107 (26.8) 202 (50.5) 27 (6.8) 28 (7.0) 36 (9.0)
8 Nutraceuticals is generally harmless. 28 (7) 234 (58.5) 58 (14.5) 52 (13.0) 28 (7.0)
9 Regular use of supplements prevents chronic diseases 54 (13.5) 188 (47.0) 90 (22.5) 42 (10.5) 26 (6.5)
10 Nutraceuticals can prevent cancers. 27 (6.8) 114 (28.5) 136 (34.0) 79 (19.8) 44 (11.0)
11 Health professional should promote use of supplements 48 (12.0) 221 (55.3) 71 (17.8) 44 (11.0) 16 (4.0)
12 Nutraceuticals should be sold only on prescription of a registered medical practitioner. 77 (19.3) 207 (51.7) 34 (8.5) 59 (14.8) 23 (5.8)
13 Manufacture and sale of nutraceuticals should be monitored by a regulatory body. 123 (30.8) 206 (51.5) 38 (9.5) 17 (4.3) 16 (4.0)
14 Use of Nutraceutical are just waste of money. 4 (1.0) 12 (3.0) 31 (7.8) 194 (48.5) 159 (39.8)

Association between socio-demographic variables and level of knowledge and attitude

The overall data on associations are presented in Table 5. There was no association between the socio-demographic variables and the patients’ knowledge level on nutraceutical (p >0.05). A significant association was found between the age of patients (p <0.001) and their attitude. Association between age group 30–44 years and moderate positive attitude and positive attitude was found to be highly significant (p <0.001). Similarly, there was an association between age group 45–49 years and positive attitude (p = 0.001). Furthermore, there was significant association between the age group above 60 years and negative attitude, moderate positive attitude, and positive attitude (p = 0.002, p <0.001, p = 0.003, respectively). No association was there with other demographic variables regarding attitude on nutraceutical.

Table 5. Association between the level of knowledge and attitude and their selected socio-demographic variables.

Variables Total Participants 400 (%) Level of knowledge Level of attitude
Inadequate Knowledge Moderate Adequate Knowledge Adequate Knowledge Chi-square value Sig Negative Attitude Moderate Positive Attitude Positive Attitude Chi square value Sig
Age (in years)
15–29 122 (30.5%) 52 (42.6%) 51 (41.8%) 19 (15.6%) 6.337 0.386 25 (20.5) 87 (71.3) 10 (8.2) 24.377 0.00
30–44 160 (40.0%) 82 (51.2%) 51 (31.9%) 27 (16.9%) 34 (21.2) 123 (76.9) 3 (1.9)
45–59 99 (24.8%) 46 (46.5%) 33 (33.3%) 20 (20.2%) 19 (19.2) 69 (69.7) 11 (11.1)
Above 60 19 (4.8%) 6 (31.6%) 10 (52.6%) 3 (15.8%) 7 (36.8) 7 (36.8) 5 (26.3)
Gender
Male 189 (47.2%) 91 (48.1%) 68 (36.0%) 30 (15.9%) 0.61 0.737 45 (23.8) 128 (67.7) 16 (8.5) 2.549 0.28
Female 211 (52.8%) 95 (45%) 77 (36.5%) 39 (18.5%) 40 (19.0) 158 (74.9) 13 (6.2)
Ethnicity
Brahmin 50 (12.5%) 20 (40%) 20 (40%) 10 (20%) 6.772 0.342 14 (28.0) 34 (68.0) 2 (4.0) 7.109 0.311
Chhetri 85 (21.2%) 42 (49.4%) 34 (40%) 9 (10.6%) 19 (22.4) 56 (65.9) 10 (11.8)
Newar 134 (33.5%) 68 (50.7%) 45 (33.6%) 21 (15.7%) 30 (22.4) 97 (72.4) 7 (5.2)
Others 131 (32.8%) 56 (42.7%) 46 (35.1%) 29 (22.1%) 22 (16.8) 99 (75.6) 10 (7.6)
Religion
Hindu 305 (76.2%) 138 (45.2%) 112 (36.7%) 55 (18%) 10.79 0.095 62 (20.3) 219 (71.8) 24 (7.9) 2.159 0.90
Buddhist 67 (16.8%) 36 (53.7%0 24 (35.8%) 7 (10.4%) 17 (25.4) 46 (68.7) 4 (6.0)
Christian 21 (5.2%) 10 (47.6%) 8 (38.1%) 3 (14.3%) 5 (23.8) 15 (71.4) 1 (4.8)
Others 7 (1.8%) 2 (28.6%) 1 (14.3%) 4 (57.1%) 1 (14.3) 6 (85.7) 0
Education
Illiterate 30 (7.5%) 17 (56.7%0 10 (33.3%) 3 (10%) 4.205 0.838 8 (26.7) 17 (56.7) 5 (16.7) 11.77 0.162
Just Read and write 42 (10.5%) 21 (50%) 12 (28.6%) 9 (21.4%) 6 (14.3) 30 (71.4) 6 (14.3)
Primary Level 34 (8.5%) 17 (50%) 11 (32.4%) 6 (17.6%) 8 (23.5) 23 (67.6) 3 (8.8)
Secondary Level 119 (29.8%) 51 (42.9%) 45 (37.8%) 23 (19.3%) 23 (19.3) 89 (74.8) 7 (5.9)
Higher secondary and above 175 (43.8%) 80 (45.7%) 67 (38.3%) 28 (16%) 40 (22.9) 127 (72.6) 8 (4.6)
Marital Status
Married 352 (88%) 167 (47.4%) 125 (35.5%) 60 (17%) 6.473 0.167 75 (21.3) 252 (71.6) 25 (7.1) 0.646 0.958
Unmarried 45 (11.2%) 19 (42.2%) 19 (42.2%) 7 (15.6%) 9 (20.0) 32 (71.1) 4 (8.9)
Divorced 3 (0.8%) 0 1 (33.3%) 2 (66.7%) 1 (33.3) 2 (66.7) 0
Occupation
Housewife 105 (26.2%) 51 (48.6%) 38 (36.2%) 16 (15.2%) 4.621 0.593 22 (21.0) 75 (71.4) 8 (7.6) 1.617 0.951
Service 112 (28.0%0 49 (43.8%) 46 (41.1%) 17 (15.2%) 23 (20.5) 82 (73.2) 7 (6.2)
Business 86 (21.5%) 41 (47.7%) 25 (29.1%) 20 (23.3%) 21 (24.4) 60 (69.8) 5 (5.8)
Others 97 (24.2%) 45 (46.4%) 36 (37.1%) 16 (16.5%) 19 (19.6) 69 (71.1) 9 (9/3)

Reasons for nutraceutical use

Majority of the patients (70%, n = 280) thought that nutraceutical had been prescribed for maintaining good health (12%, n = 48) reportedly perceived its use for enhancing appearance, (4.5%, n = 18) believed weight loss is the reason for its prescription and very few (3.75%, n = 15) thought that nutraceutical was prescribed with no reason (Table 6).

Table 6. Patient’s perception on reason for nutraceutical use.

Reason Total 400 (%)
Maintain good health 280 (70)
Treatment of disease 157 (39.25%)
Prevent disease 142 (35.5%)
Ensure adequate nutrition 125 (31.25%)
Meet increased energy needs 97 (24.25%)
Enhance appearance 48 (12%)
Weight Loss 18 (4.5%)
No specific reason 15 (3.75%)

Cost comparison of prescribed nutraceuticals

The present study showed that the average amount that a patient spent on nutraceutical was NRs. 575.78 [equivalent to USD 4.85] per prescription, the maximum accounted to NRs. 757.18 [equivalent to USD 6.38] in Orthopedics and minimum ranged to NRs. 399.03 [equivalent to USD 3.36] in obstetrics and gynecology OPD. A significant difference was found in the cost of nutraceuticals among the various OPD (p <0.001). Based on a post hoc test (LSD) analysis, there was a significant difference in the cost of nutraceutical prescribed among the various OPD clinics except in medicine–obstetrics and gynecology OPD (p = 0.067). Table 7 shows details.

Table 7. Comparison of cost of nutraceutical prescribed department wise (One way ANOVA).

OPD N Mean ± SE 95% Confidence Interval for Mean P -Value
Lower Bound Upper Bound
Medicine 100 511.95 ± 44.75 423.15 600.75
Surgical 100 634.99 ± 44.60 546.48 723.49
Orthopedic 100 757.18 ± 48.30 661.32 853.03 <0.001
Obstetrics and Gynecology 100 399.03 ± 35.05 329.47 468.58
Total 400 575.78 ± 22.66 531.23 620.33

Discussion

The current study aimed to quantify the frequency of concomitant use of nutraceutical, an important area of ongoing clinical concern along with assessing patients’ preferences related to information sources consulted and patients’ KAP regarding nutraceutical. Our data shows that there is a huge gap between the knowledge and practices among the patients for nutraceutical use in Nepal, suggesting the need for educational intervention to increase public awareness on the rational use of nutraceutical.

The present study showed that majority of the patients (81.2%) were already consuming nutraceutical. This demonstrates that use of nutraceutical by patients has become a common practice for a myriad of reasons in Nepal. For instance, the preference to the use of these nutraceutical could be explained by individual’s perception that nutraceutical aids in treating their ailments and lack of nutraceutical is accountable for various disorders [19]. Further to these, physicians perception towards nutraceutical as having beneficial effect has also resulted the possible rise in the prescription of nutraceutical in out-patient departments [20] as observed in our study. Besides, individuals’ increased consciousness towards their health has led to an escalated demand for nutritious products as a health booster. Nutraceutical thus has gained popularity in the general population as an essential element of a regular balanced diet [17, 21]. Vitamins were the most widely prescribed nutraceutical in our study, followed by minerals, enzymes, and herbal. This finding is in line of agreement with the study conducted in India among the health science students [22]. A similar relatively high consumption (43%, n = 105) of vitamin-mineral supplements has been observed among the university students in Malaysia [20].

Despite the higher use of nutraceutical, our study showed that very less proportion of patients (17.3%) were aware of the term nutraceutical. Our finding showed a huge difference with the previous study conducted by Navyashree et al., which reported a higher proportion (76%, n = 38) were aware of the term nutraceutical [23]. A total of 31.8% of participants believed that nutraceutical is not always devoid of side effects which is lesser than that reported by the author (72%, n = 36). Majority of the participants (46.5%, n = 186) had inadequate knowledge of nutraceutical. This difference may be accounted to the fact that the author had conducted the study among medical practitioners in a tertiary care hospital, unlike our study, which assessed the KAP of patients visiting the hospital. An overestimation of nutraceutical safety among people should be a matter of concern as reported by this study. Regulation of dietary supplements by the FDA is relatively liberal in terms of safety requirements. However, the consumption of dietary supplements is not without risk. Photosensitivity and neurotoxicity at higher doses of pyridoxine, toxicity resulting from increased consumption of fat-soluble vitamins, an association of congenital abnormalities with increased prevalence of vitamin A consumption during pregnancy have been reported. Hence contemplation of potential interactions and adverse effects of dietary supplements is essential to avoid harmful medical sequel. It is equally important for the consumers and the physicians to refer to evidence-based literature or credible resources before initiating such supplements. Since dietary supplements have become a common, physicians and pharmacists should inquire well about supplement intake history to avoid any possible drug supplement interactions [24].

Majority of the participants (81.2%, n = 325) in our study were using some kind of nutraceutical, showing a huge differences in data as presented by Alhoumoud et al. (37%, n = 74) among the non-medical students in one of the universities of United Arab Emirates (UAE) [16]. Most of the participants (85.2%, n = 341) sought professional medical help before taking nutraceutical, which is higher than that reported by the author (44%, n = 88) [16]. Furthermore, (87.5%, n = 350) of our participants believed that counselling is essential before consuming nutraceutical. This reflects the trust put upon the healthcare professionals by the patients and their expectation of receiving credible information from the healthcare professionals on nutraceutical. The fact that maximum patients purchase nutraceutical from nearby hospital pharmacy (58%, n = 232) following physicians’ prescription (72.5%, n = 290) supports the statement mentioned above.

Regarding the attitude towards nutraceuticals, majority of participants perceived that nutraceuticals prevent chronic diseases (60.5%, n = 242) or even cancer (35.3%, n = 141) in contrary to the findings of Gosavi et al., where none of the patients believed that nutraceuticals had been prescribed to prevent chronic illnesses [17]. Despite the prominent use of nutraceuticals, a sheer lack of clinical evidence to reinforce the health claim of chronic disease or cancer prevention has been reported [18, 24]. The majority felt the need for some regulatory body to survey the manufacture and sale of nutraceuticals and voted for its’ categorization under prescription-only products. The participants were also in favor of healthcare professionals promoting the use of nutraceutical. This result is consistent with Navyashree et al., where the medical practitioners stated the need to regulate nutraceuticals and were against its availability as over the counter (OTC) products [23]. A small proportion of the patients, 9.8%,, also believed that nutraceutical could be a complete substitute for meals which is slightly lower to the data obtained by Cruz et al. where 17.5% possessed such perceptions [14]. Such beliefs among people might lead to behaviors like skipping of meals and overuse of nutraceuticals. Hence, we, the present authors, suggest the attention of healthcare professionals must be drawn to such areas where patients need to be counselled appropriately.

Our study showed that majority of the patients (70%), mainly perceived nutraceutical as drugs which help to maintain good health, 39.25% thought the use can aid in the treatment of their illnesses 31.25% ensure adequate nutrition and 35.5% prevent diseases. Similar findings were reported by Teoh SL et al. in which maintenance of good health, preventing future illnesses along with perceived health benefits of nutraceuticals especially in the current situation where consumption of fruits and vegetables loaded with pesticides pose a significant challenge in sustaining health condition of the general public were identified as the main factors affecting the consumer’s decision to consume nutraceutical [18].

The reasons for nutraceutical use outlined in our research are also consistent with the findings of a few other studies conducted among university students in Malaysia and Saudi Arabia [22, 25, 26]. Nevertheless, reasons like improving mental performance, body function and general well-being recorded by Abdullah and Waquar [27] were not mentioned by our participants. Despite the potential benefits of nutraceutical, the public needs to understand that a balanced diet and healthy lifestyle are essential facets of good health, and nutraceutical alone cannot be a substitute. Furthermore, consumers must be aware that nutritional supplements should not be looked upon as replacements of medical therapy to cure or treat a disease condition, and equally valid because supplements are not devoid of side effects and interactions with other medications [16].

Healthcare professionals, internet, television, followed by books were reported to be the most common sources of information on nutraceutical. This observations was not surprising as this aligns with the previous studies finding [22, 26]. Healthcare professionals, especially physicians and pharmacists, remain in a highly trusted position to offer drug or disease-related credible information and therefore we suggest that there should be updated knowledge on the use of nutraceutical among healthcare professionals. Besides, in this era of virtually limitless information, healthcare professionals should offer guidance to the users on identifying and obtaining credible sources of information on nutraceutical. Physicians, pharmacists and books can provide more trustworthy and evidence-based information to nutraceutical users compared to television advertisement [16].

Our study showing that maximum of NRs. 757.18 [equivalent to USD 6.38] was spent in Orthopedics and a minimum of NRs. 399.03 [equivalent to USD 3.36] spent in Obstetrics and gynecology department by the patients is in the range of previous study suggesting the similar expenditure in respective department [17]. Accordingly, we also found that 88.3% (n = 353) of the participants did not regard expenditure on nutraceuticals as a waste of money. Instead, our observation showed that many of the participants believed nutraceuticals serving as a supplement source of nutrition that cannot be adequately received from food. Nutraceuticals are gaining a widespread market share globally, with China and India taking giant leaps as the fast-moving markets [12] and thus Nepal cannot remain untouched by this influential global growth rate. Although, the price of nutraceuticals has been identified as a determining factor to its purchase and consumption, its use has also been anticipated by many as a way of preventing chronic illnesses which may cost them a more significant deal of money [18].

With the observations in context to nutraceutical use in Nepal, the present authors suggest health benefits claimed by manufacturers of functional foods or food ingredients with health outcomes needs to be backed by scientific evidence and significant scientific agreement. Given the market appeal and claims made by nutraceutical, sufficient legislations to safeguard the health of the population are urgently warranted in Nepal.

Conclusion

There is a relatively high prevalence of nutraceutical consumption among patients due to their high perception that it is necessary to maintain good health and ensure adequate nutrition. The high prevalence may be due to the information suggested by the healthcare professionals, most of whom consume it following a physician’s prescription. Our study shows that most of the patients possessed a moderately positive attitude but nearly one half of the study population had inadequate knowledge regarding nutraceutical. With these observations, we suggest awareness of nutraceutical use, and information should be integrated into everyday practice to ensure the proper use of nutraceutical related products. There is a continuing need for nutraceutical consumers to be educated to determine the appropriate use of these supplements.

Strength and limitations

To the best of our knowledge, this is the first study in Nepal to date reporting the nutraceutical use among patients. Similarly, this is the first study in the country that has attempted to address the gap regarding KAP of patients on nutraceuticals. This study offers the baseline data to other researchers willing to perform large scale research on the relevant topic.

However, our study has some limitations. The study was a cross-sectional study, and therefore, it gave only a snapshot of participants KAP relating to nutraceutical. It was carried out only in a particular hospital, and the result obtained from this cannot be generalized at the national level. This study assessed the KAP of only those who were either consuming or were prescribed with nutraceutical, which can lead to participant bias and/or response bias for assessing KAP of nutraceutical. Furthermore, the influence of predictor variables and their co-relation for KAP was not included in the present study.

Recommendation

Studies assessing the KAP of healthcare professionals regarding nutraceuticals in Nepal is an important area requiring exploration. Nutraceutical use among the general public needs to be studied on a larger scale. There is a call for interventional studies that can improve the KAP of patients and consumers on nutraceutical.

Supporting information

S1 File. Questionnaire English version.

KAP questionnaire.

(DOCX)

S1 Data. Data in Excel.

(XLSX)

S2 Data. Data in SPSS.

(SAV)

Acknowledgments

The author (s) would like to thank Associate Professor Dr Rajani Shakya, Head of Department of Pharmacy, Kathmandu University and Mr Tara Jung Gurung, PhD for their co-operation and extreme support and guidance. The author (s) would like to thank Scheer Memorial Adventist Hospital, Banepa, Kavre, Nepal, for permission to conduct the study. The author(s) would like to acknowledge all the study participants.

Data Availability

All relevant data are within the paper and its supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Brower V. Nutraceuticals: poised for a healthy slice of the healthcare market? Nat Biotechnol. 1998;16(8):728–31. Epub 1998/08/14. doi: 10.1038/nbt0898-728 . [DOI] [PubMed] [Google Scholar]
  • 2.Trottier G, Boström PJ, Lawrentschuk N, Fleshner NE. Nutraceuticals and prostate cancer prevention: a current review. Nat Rev Urol. 2010;7(1):21–30. Epub 2009/12/10. doi: 10.1038/nrurol.2009.234 . [DOI] [PubMed] [Google Scholar]
  • 3.Bagchi D. Nutraceutical and functional food regulations in the United States and around the world: Elsevier; 2014. [DOI] [PubMed] [Google Scholar]
  • 4.Nutraceutical Market Size, Share & Trends Analysis Report By Product (Dietary Supplements, Functional Foods, Functional Beverages), By Region, And Segment Forecasts, 2020–2027 [cited 2021 February 6]. Available from: https://www.grandviewresearch.com/industry-analysis/nutraceuticals-market.
  • 5.Nutraceuticals: the front line of the battle for consumer health [cited 2021 February 6]. Available from: https://www.es.kearney.com/consumer-retail/article/?/a/nutraceuticals-the-front-line-of-the-battle-for-consumer-health.
  • 6.Santini A, Cammarata SM, Capone G, Ianaro A, Tenore GC, Pani L, et al. Nutraceuticals: Opening the debate for a regulatory framework. British journal of clinical pharmacology. 2018;84(4):659–72. doi: 10.1111/bcp.13496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Southeast Asia Dietary Supplements Market Size, Share & Industry Analysis, By Type (Vitamins, Minerals, Enzymes, Fatty Acids, Proteins, and Others), Form (Tablets and Capsules, Powder, and Liquid), and Regional Forecasts, 2019–2026 [cited 2021 February 6]. Available from: https://www.fortunebusinessinsights.com/industry-reports/southeast-asia-dietary-supplements-market-101943.
  • 8.WHO. Technical consultation: Nutrition-related products and the WHO Model List of Essential Medicines: practical considerations and feasibility [cited 2021 February 6]. Available from: https://www.who.int/nutrition/events/2018-consultation-model-list-essential-medicines-scopeandpurpose-20to21Sept.pdf?ua=1.
  • 9.Shao A. Global adverse event reporting regulations for nutraceuticals, functional foods, and dietary/food/health supplements. Nutraceutical and functional food regulations in the United States and around the world: Elsevier; 2019. p. 619–24. [Google Scholar]
  • 10.Curtis CL, Harwood JL, Dent CM, Caterson B. Biological basis for the benefit of nutraceutical supplementation in arthritis. Drug Discov Today. 2004;9(4):165–72. Epub 2004/02/13. doi: 10.1016/S1359-6446(03)02980-5 . [DOI] [PubMed] [Google Scholar]
  • 11.Chen QM, Alpert JS. Nutraceuticals: evidence of benefit in clinical practice? The American journal of medicine. 2016;129(9):897–8. doi: 10.1016/j.amjmed.2016.03.036 [DOI] [PubMed] [Google Scholar]
  • 12.Lamichhane GP, Prakash Raj Regulatory aspects of nutraceuticals and functional foods in Nepal. Nutrafoods. 2020(2):186–92. [Google Scholar]
  • 13.Mahmood NA, Hassan MR, Ahmad S, Mohd Nawi H, Pang NTP, Syed Abdul Rahim SS, et al. Nutraceutical Use among Patients with Chronic Disease Attending Outpatient Clinics in a Tertiary Hospital. Evidence-Based Complementary and Alternative Medicine. 2020;2020. doi: 10.1155/2020/9814815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cruz AJ, Tanchoco CC. Survey on awareness, perception, and extent of usage of nutraceuticals and dietary supplements in metro manila. J Med Food. 2000;3(4):181–8. Epub 2000/01/01. doi: 10.1089/jmf.2000.3.181 . [DOI] [PubMed] [Google Scholar]
  • 15.Raosoft. Sample Size Calculator. Available from: http://www.raosoft.com/samplesize.html.
  • 16.Alhomoud FK, Basil M, Bondarev A. Knowledge, attitudes and practices (KAP) relating to dietary supplements among health sciences and non-health sciences students in one of the universities of United Arab Emirates (UAE). Journal of Clinical and Diagnostic Research: JCDR. 2016;10(9): JC05. doi: 10.7860/JCDR/2016/19300.8439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gosavi S, Subramanian M, Reddy R, Shet BL. A study of prescription pattern of neutraceuticals, knowledge of the patients and cost in a tertiary care hospital. Journal of Clinical and Diagnostic Research: JCDR. 2016;10(4): FC01. doi: 10.7860/JCDR/2016/18424.7620 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Teoh SL, Ngorsuraches S, Lai NM, Bangpan M, Chaiyakunapruk N. Factors affecting consumers’ decisions on the use of nutraceuticals: a systematic review. Int J Food Sci Nutr. 2019;70(4):491–512. Epub 2019/01/13. doi: 10.1080/09637486.2018.1538326 . [DOI] [PubMed] [Google Scholar]
  • 19.Nasri H, Baradaran A, Shirzad H, Rafieian-Kopaei M. New concepts in nutraceuticals as alternative for pharmaceuticals. International journal of preventive medicine. 2014;5(12):1487. [PMC free article] [PubMed] [Google Scholar]
  • 20.R N, Rai M, Ravindran A. Awareness And Practices Towards Nutraceuticals Among Medical Practitioners of A Tertiary Care Teaching Hospital in South India—A Pilot Study. IOSR Journal of Dental and Medical Sciences. 2017;16:12–6. doi: 10.9790/0853-1605061216 [DOI] [Google Scholar]
  • 21.Klopčič M, Slokan P, Erjavec K. Consumer preference for nutrition and health claims: A multi-methodological approach. Food Quality and Preference. 2020;82:103863. [Google Scholar]
  • 22.Sharma A, Adiga S. Knowledge, attitude and practices related to dietary supplements and micronutrients in health sciences students. Journal of clinical and diagnostic research: JCDR. 2014;8(8): HC10. doi: 10.7860/JCDR/2014/9329.4683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Navyashree R, Rai M, Ravindran A. Awareness And Practices Towards Nutraceuticals Among Medical Practitioners of A Tertiary Care Teaching Hospital in South India-A Pilot Study. [Google Scholar]
  • 24.Ronis MJJ, Pedersen KB, Watt J. Adverse Effects of Nutraceuticals and Dietary Supplements. Annu Rev Pharmacol Toxicol. 2018;58:583–601. Epub 2017/10/11. doi: 10.1146/annurev-pharmtox-010617-052844 ; PubMed Central PMCID: PMC6380172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Al-Johani WM, Al-Dawood KM, Wahab MMA, Yousef HA. Consumption of vitamin and mineral supplements and its correlates among medical students in Eastern Province, Saudi Arabia. Journal of family & community medicine. 2018;25(3):169. doi: 10.4103/jfcm.JFCM_156_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Al-Naggar RA, Chen R. Prevalence of vitamin-mineral supplements use and associated factors among young Malaysians. Asian Pac J Cancer Prev. 2011;12(4):1023–9. [PubMed] [Google Scholar]
  • 27.Abduallah B, Waquar A. Consumption pattern of nutraceutical products among consumers in Delhi. Indian J Appl Res. 2013;3:169–72. [Google Scholar]

Decision Letter 0

Jenny Wilkinson

22 Dec 2020

PONE-D-20-36161

Prescription pattern and costs of nutraceuticals visiting out-patient department in Nepal and their knowledge, attitude, practice towards nutraceuticals: A cross-sectional study

PLOS ONE

Dear Dr. shrestha,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Jenny Wilkinson, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.) We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript

  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3.) You indicated that you had ethical approval for your study.

In your Methods section, please ensure you have also stated whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB specifically waived the need for their consent.

4.) Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

Additional Editor Comments:

Thank you for your submission. Reviewers have provided detailed comments which are provided for your consideration. Both reviewers have also noted that the manuscript need editing for English language and you may wish to seek assistance from a professional editing service for this task.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Title: Title statement (“……visiting OPD in Nepal and”) seems strange it should rather be “..Hospital OPD in Nepal” . As categorizations/ operational definition of nutraceutical wasn't clear (see below comments in method section ), "More Precisely, I suggest the title something like “Evaluation of Nutritional supplements prescribed, its associated Cost and Patients knowledge, attitude and practice towards Nutraceuticals: A hospital based cross-sectional study in Kabrepalanchok, Nepal”

Abstract :

In methods, please mention the statistical test used during data analysis.

Introduction:

Citation of the original source (instead of reference provided) is recommended particularly in paragraph 2. Author are advised not to provide the assumed hypothetical or contradictory statements regarding study intention and outcomes of study as laid down in paragraph 4 and 5 of the introduction section beside the rationale of the study needs be properly stated. The flow and smoothness in and during transition of paragraph need to be improved.

I also wish to also see a literature body related to advantages/ disadvantages associated with chaotic use of nutraceuticals, factors influencing consumer’s/prescribers attitude regarding nutraceuticals, marketing and regulatory facts regarding the sale and distribution of Nutraceutical particularly in content to Nepal all in one to two paragraph within the acceptable word count limit.

Methods:

Inclusion criteria: you have mentioned “those who were prescribed nutraceuticals” will be enrolled in study. Though the inclusion is appropriate for evaluating of prescribing pattern. However, this can strongly introduce participant bias and/or response bias for assessing KAP of nutraceutical.

Exclusion criteria: what about the geriatric and/or mentally retarded patients?

sampling techniques: Author have mentioned “stratified random sampling” in abstract whereas stratified purposive sampling is stated in methods section. Author is advice to reconcile the contradict section. please mention how much sample size is taken from each departments with justification.

Data collection tools and techniques:

Author is advised to cite the references article reviewed or undertaken while designing the tools/questionnaire of the study. Please state the mean score value for adequate, moderately adequate and inadequate knowledge, similarly for positive, moderately positive and negative attitude.

Prescribing pattern categories of nutraceutical which you have laid down is not clear. Is there any appropriate references followed to classify nutraceutical? In my understanding. There are marginal differences between the nutraceutical (which are generally understood for food derived dietary supplements) and pharmaceutical supplements (which actually contains pharmaceutically active ingredients, properly dose regulated and quality controlled e.g specific active vitamins supplement, folic acid, calcium and iron tablets). While both are nutritional health supplements, differentiation is important for better clarity (as pharmaceutical single or multiple doses form supplements are widely used /and are important in medical therapy while nutraceutical are often comes a dietary supplements and are not necessarily regulated and doesn’t require prescription, particularly in country like Nepal). Therefore, proper characterization of the types of nutraceutical needs to be done as per study aim else the readers may misinterpret the findings.

Data analysis and Results:

Prescribing pattern of Nutraceuticals:

You have mention in inclusion criteria as “Patients who were prescribed nutraceutical” are enrolled in study. The first line reads 80 % of patients are using/prescribed nutraceuticals? please clarify.

Table 2. Kindly find comments in methods section regarding categorization of nutraceuticals. I don’t think as per your study aim, there is any significance of tabulating the nutritional supplements categories as per the use by departments.

Tables could be made more concise and reader friendly , for e.g presenting the gender wise distribution of knowledge, attitude related table (table 3 and 8) in a single table, and similarly association related table (table 4 and 6) in another table, while illustrating the significant results in text.

Data analysis remarks: you have used chi square test to determine the relationship between sociodemographic groups and KA level ( many of those consisting with 4/5*3 consistency table). Analysis with chi square to determine relationship in such cases may not be appropriate, and in many instances requires post hoc test for chi square for identifying where the significant association lies (if any) .

Alternatively, distributing relevant sociodemographic variables (such as age, gender, literacy level, Marital status, employment status etc) wisely into binary group and then getting it compared with frequency score (using chi square) or with the mean/median score of Knowledge and attitude (e.g using t test, Anova, Mann-whitney, KW test for means which ever suitable) may be more appropriate.

Besides, determining the influence of predictor variables like age, literacy status, employment status etc and/or their co-relation for KAP will further strengthen the findings?

Table 7. Since it’s the patient’s perceived response to nutraceutical been prescribed, I don’t see any rationale for presenting it in a distributive form with respect to OPD clinics.

Table 9. Finding of Post hoc test for ANOVA can be explained in text and need not necessarily be presented in table.

Discussion:

Discussion needs refinements.

Strength and implication can be provided after the conclusion instead of first paragraph.

Some of the important background information are being highlighted in discussion (can be rearrange to Introduction section)

The transition of paragraph needs to be properly arranged as per the order of finding of the result. Author are advised to compared their findings to more of the relevant/similar research literature of other developed and developing countries including that of South-Asian countries in terms of nutraceutical use and patients KAP.

Conclusion: Conclusion should be based only as per the finding of your study. Additional suggestion and recommendation could be made separately in recommendation section.

General comments: The article requires improvements in English, possible proof reading by native English speaker or professional expert/ services is recommended.

Reviewer #2: Overall impression, the language and formatting were poorly done. The major concern about the paper is the methodological aspect, especially the sampling population and the content of the questionnaire. The methods despite not clearly described, do not seem to me to have reached a scientific enough level.

Some other specific comments:

Abstract

1) Not convinced with the implication of use of the research that has been described in the abstract's conclusion.

2) Please use a more appropriate language for "Vitamins were prescribed maximum in medicine ".

Introduction

1) Line 82-87 describes about the use of nutraceuticals for malnutrition using WHO's statistics. I am not agreeable to the purpose of the use of nutraceuticals in your context. I believe the participants here were taking nutraceuticals for "dietary supplementation" instead of "malnutrition". Malnutrition is normally for those in critical environment.

Method

1) Line 119-120 "The total population of a patient visiting OPD was 22500 (with an average 250 per day) in three-month

duration according to hospital census." should be in results instead of methods or after the descriptions of sampling method.

2) Line 124 - 127 - "A questionnaire was designed after reviewing the previous similar studies with some

modifications. Structured questions were used for the collection of data, and the prescriptions and

bills were scrutinized" - I am not convinced about the appropriateness of the content of the developed questionnaires.

3) There were no referred versions to be seen. No experts to examine the content of questionnaire?

3) Line 128 - participants were randomly selected? How? It was not described

4) Line 149-150 - How the calculation of "the average percentage of costs spent on nutraceutical

150 alone compared to the total prescribed drugs were measured following OPD." is performed, it is not clearly described.

Results

1) 201 - "Do you know what nutraceutical are?" Does not seem to be accurately testing the content of the "knowledge" of participants. "Nutraceuticals" itself is a very jargonish term even researcher of healthcare providers may not be aware of.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 4;16(6):e0252538. doi: 10.1371/journal.pone.0252538.r002

Author response to Decision Letter 0


18 Feb 2021

Dear Editor

We have submitted all the changes and addressed all the comments of the reviewers in the tracked changed version of manuscript and the response sheet.

Attachment

Submitted filename: Response Sheet.docx

Decision Letter 1

Jenny Wilkinson

3 Mar 2021

PONE-D-20-36161R1

Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards Nutraceuticals: A hospital based cross-sectional study in Kavrepalanchowk, Nepal

PLOS ONE

Dear Dr. shrestha,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 17 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Jenny Wilkinson, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Thank you for your responses; these have largely addressed the reviewer comments. There are however still several grammatical and other language errors and I encourage you to seek assistance from a native English writer or professional editorial service. I also ask that you use only a single track change author as multiple authors result in many different coloured track changes which makes it quite difficult to read.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 4;16(6):e0252538. doi: 10.1371/journal.pone.0252538.r004

Author response to Decision Letter 1


16 Apr 2021

16th April, 2021

Response to reviewers

Dear Editor,

Thank you very much for providing us the comments on improving the manuscript level as per the Plos One standard. We believe that the revised version of the manuscript has been improved as a result of the reviewers’ comments and feedback and the re-revised version has been successful in meeting the Plos One standard, particularly improving the English level (as per the additional editor comments) and the editor comments on cross-checking the references to respond the retracted article in proper way (if any).

Please find the revised manuscript “Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards Nutraceuticals: A hospital based cross-sectional study in Kavrepalanchowk, Nepal”.

As per the suggestion from editor, we have used the fluent English writer to have a look at our manuscript and thus we believe that the quality of the manuscript has been improved. We also have used single level of track changes mode-on for not adding difficulty to editor to assess the changes made. At some places, the manuscript has been edited for brevity.

Best wishes

Sweta Shrestha

Attachment

Submitted filename: Response-to-reviewers (1).docx

Decision Letter 2

Jenny Wilkinson

4 May 2021

PONE-D-20-36161R2

Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards Nutraceuticals: A hospital based cross-sectional study in Kavrepalanchowk, Nepal

PLOS ONE

Dear Dr. shrestha,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jenny Wilkinson, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Thank you for your revisions, while the content related issues have been addressed there are still many grammatical and language issues. For example, the sentence “Many schools and universities started switching from traditional classroom teaching to virtual education methods” is repeated at the top of page 3, ‘et al’ is incorrectly shown with full stops after both et and al and author initials included in in-text citations, etc. I strong advise seeking assistance from a native English writer experience in academic writing or professional editing service.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 4;16(6):e0252538. doi: 10.1371/journal.pone.0252538.r006

Author response to Decision Letter 2


7 May 2021

Date: 7th May 2021

Jenny Wilkinson, PhD

Academic Editor

PLOS ONE

Subject: Response to Editor and submission of the revised version of the manuscript

Dear editor,

Thank you very much for providing us with the comments on improving the manuscript level as per the Plos One standard. We have revised manuscript titled “Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards Nutraceuticals: A hospital based cross-sectional study in Kavrepalanchowk, Nepal”, Manuscript ID: PONE-D-20-36161R2 and submitting you the revised manuscript in both track changes and clean version.

We have mentioned a point-to-point response below to the comments by the editor.

Yours Sincerely,

Sweta Shrestha on behalf of the study team.

Comments:

Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response: We believe that the revised version of the manuscript has been improved because of the reviewers’ comments and feedback, and the re-revised version has been successful in meeting the Plos One standard, particularly improving the English level (as per the additional editor comments) and the editor comments on cross-checking the references to respond the retracted article properly (if any).

Additional Editor Comments (if provided):

Thank you for your revisions, while the content related issues have been addressed there are still many grammatical and language issues. For example, the sentence “Many schools and universities started switching from traditional classroom teaching to virtual education methods” is repeated at the top of page 3, ‘et al’ is incorrectly shown with full stops after both et and al and author initials included in in-text citations, etc. I strong advise seeking assistance from a native English writer experience in academic writing or professional editing service.

Response: The sentence “Many schools and universities started switching from traditional classroom teaching to virtual education methods” you mentioned is not mentioned in our manuscript. We believe that there is some confusion. Please kindly verify it once. As per the suggestion from the editor, we have used a fluent English writer to look at our manuscript, and thus we believe that the quality of the manuscript has been improved. We have also used the single level of track changes mode to make it easier for the editor to assess the changes made. At some places, the manuscript has been edited for brevity.

Attachment

Submitted filename: Response-to-reviewers (1).docx

Decision Letter 3

Jenny Wilkinson

18 May 2021

Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards Nutraceuticals: A hospital based cross-sectional study in Kavrepalanchowk, Nepal

PONE-D-20-36161R3

Dear Dr. shrestha,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jenny Wilkinson, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Jenny Wilkinson

24 May 2021

PONE-D-20-36161R3

Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards Nutraceuticals: A hospital based cross-sectional study in Kavrepalanchowk, Nepal

Dear Dr. Shrestha:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Jenny Wilkinson

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Questionnaire English version.

    KAP questionnaire.

    (DOCX)

    S1 Data. Data in Excel.

    (XLSX)

    S2 Data. Data in SPSS.

    (SAV)

    Attachment

    Submitted filename: Response Sheet.docx

    Attachment

    Submitted filename: Response-to-reviewers (1).docx

    Attachment

    Submitted filename: Response-to-reviewers (1).docx

    Data Availability Statement

    All relevant data are within the paper and its supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES